Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this research on the evidence for a causal relationship between cannabis and schizophrenia and for other genetic associations relating to substance use and psychiatric disorders. The episode also covers to ever-fascinating issue of mendelian randomisation.

(Be sure to check out episode 22 too!)

The original article can be found here: Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R, Murray R.M., Edenberg H.J., et al. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction 2021 https://doi.org/10.1111/add.15534


The opinions expressed in this post and podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Share this story